Balyasny Asset Management’s VYNE Therapeutics VYNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q3
Sell
-165
Closed -$96K 1795
2018
Q2
$96K Buy
+165
New +$96K ﹤0.01% 1531